Association of UCP2 −866 G/A polymorphism with chronic inflammatory diseases

被引:0
作者
X Yu
S Wieczorek
A Franke
H Yin
M Pierer
C Sina
T H Karlsen
K M Boberg
A Bergquist
M Kunz
T Witte
W L Gross
J T Epplen
M E Alarcón-Riquelme
S Schreiber
S M Ibrahim
机构
[1] Section of Immunogenetics,Department of Human Genetics
[2] University of Rostock,Department of Genetics and Pathology
[3] Ruhr University,Medical Department IV
[4] IGSN,Department of General Internal Medicine
[5] Institute of Clinical Molecular Biology,Medical Department
[6] Christian-Albrechts-University,Department of Gastroenterology and Hepatology
[7] Uppsala University,Department of Immunology and Rheumatology
[8] University of Leipzig,Department of Rheumatology
[9] University Hospital Schleswig-Holstein,undefined
[10] Christian-Albrechts-University,undefined
[11] Rikshospitalet University Hospital,undefined
[12] Karolinska University Hospital,undefined
[13] Dermatology Clinic,undefined
[14] University of Rostock,undefined
[15] Medical School Hannover,undefined
[16] University Hospital of Schleswig-Holstein,undefined
[17] Campus Luebeck,undefined
来源
Genes & Immunity | 2009年 / 10卷
关键词
mitochondria; chronic inflammatory diseases; uncoupling protein 2;
D O I
暂无
中图分类号
学科分类号
摘要
We reported earlier that two mitochondrial gene polymorphisms, UCP2 –866 G/A (rs659366) and mtDNA nt13708 G/A (rs28359178), are associated with multiple sclerosis (MS). Here we aim to investigate whether these functional polymorphisms contribute to other eight chronic inflammatory diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Wegener' granulomatosis (WG), Churg–Strauss syndrome (CSS), Crohn's disease (CD), ulcerative colitis (UC), primary sclerosing cholangitis (PSC) and psoriasis. Compared with individual control panels, the UCP2 –866 G/A polymorphism was associated with RA and SLE, and the mtDNA nt13708 G/A polymorphism with RA. Compared with combined controls, the UCP2 –866 G/A polymorphism was associated with SLE, WG, CD and UC. When all eight disease panels and the original MS panel were combined in a meta-analysis, the UCP2 was associated with chronic inflammatory diseases in terms of either alleles (odds ratio (OR)=0.91, 95% confidence interval (95% CI): 0.86–0.96), P=0.0003) or genotypes (OR=0.88, (95% CI: 0.82–0.95), P=0.0008), with the –866A allele associated with a decreased risk to diseases. As the −866A allele increases gene expression, our findings suggest a protective role of the UCP2 protein in chronic inflammatory diseases.
引用
收藏
页码:601 / 605
页数:4
相关论文
共 70 条
[1]  
Taylor RW(2005)Mitochondrial DNA mutations in human disease Nat Rev Genet 6 389-402
[2]  
Turnbull DM(2001)Mouse models for mitochondrial disease Am J Med Genet 106 71-93
[3]  
Wallace DC(2006)Mitochondria, apoptosis and autoimmunity Curr Dir Autoimmun 9 55-73
[4]  
Pinkoski MJ(2005)Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis J Mol Med 83 806-811
[5]  
Waterhouse NJ(1995)Mitochondrial DNA mutations in multiple sclerosis Mult Scler 1 32-36
[6]  
Green DR(2008)mtDNA nt13708A variant increases the risk of multiple sclerosis PLoS ONE 3 e1530-183
[7]  
Vogler S(2001)A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans Nat Genet 28 178-485
[8]  
Goedde R(2004)Uncoupling protein 2 promoter polymorphism −866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients Diabetes 53 482-439
[9]  
Miterski B(2000)Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production Nat Genet 26 435-5833
[10]  
Gold R(1999)Retinoids activate proton transport by the uncoupling proteins UCP1 and UCP2 EMBO J 18 5827-1575